By
Treatment Action Group,
OTMeds
Published: Aug. 3, 2020, 8:04 p.m.·
Tags:
Prevention,
Advocacy
TAG and OTMeds call on Sanofi to reverse its efforts to patent two obvious combinations of two critical drugs to prevent TB: rifapentine and isoniazid.
Read More →
By
Treatment Action Group,
OTMeds
Published: Jan. 22, 2020, 1:55 p.m.·
Tags:
Prevention,
Access,
Advocacy
Activists urge Sanofi to do the same in other countries.
Read More →